Pinz Capital Management, LP Vectiv Bio Holding Ag Transaction History

Pinz Capital Management, LP

$55.2 Million
Q3 2022

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$4.6 - $5.8 $276,432 - $348,545	-60,094 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.83 - $7.26 $34,019 - $87,272	12,021 Added 25.01%	60,094 $295,000
Q3 2021 Nov 15, 2021	BUY	$6.7 - $11.54 $117,330 - $202,088	17,512 Added 57.3%	48,073 $371,000
Q2 2021 Aug 16, 2021	BUY	$11.66 - $24.23 $356,341 - $740,493	30,561 New	30,561 $356,000

Others Institutions Holding VECT

# of Institutions

1

Shares Held

510K

Call Options Held

0

Put Options Held

0

Regency Capital Management Inc.\De

510K
Shares

$0
0.0% of portfolio

About VectivBio Holding AG

Ticker VECT
Exchange NASDAQ
Description
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...

More about VECT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.